Did the company provide any guidance or outlook for Q3 2025 or the full‑year 2025?

Answer

Based on the information contained in the Cardlytics second‑quarter 2025 earnings release (the excerpt you provided), the company did not include any specific guidance or outlook for the third quarter of 2025 (Q3 2025) or for the full‑year 2025.

What the release does contain

• A statement from CEO Amit Gupta about the company’s strategic focus—doubling down on diversification and leveraging its network capabilities.
• A general comment that these “strategic shifts will position us for long‑term profitable growth,” but no quantitative or qualitative forecasts were attached to that statement.

What is missing

• No projected revenue, net income, adjusted EBITDA, or other key financial metrics for Q3 2025.
• No full‑year 2025 financial targets, operating‑margin expectations, or cash‑flow outlook.
• No commentary on expected capital‑expenditure, customer‑acquisition plans, or macro‑economic assumptions that would typically accompany a forward‑looking guidance section.

Implications

• Investors and analysts looking for forward‑looking guidance will need to seek additional information—either from a later press release, a conference call transcript, or a filing with the SEC (e.g., a Form 8‑K or a 10‑Q) that might contain a “Management Discussion and Analysis” (MD&A) section with guidance.
• Market expectations may therefore be based primarily on historical performance and the qualitative strategic commentary provided, rather than on concrete financial targets for the upcoming quarter or the remainder of the year.

What you can do next

1. Check the full press release – The excerpt you have may be truncated. The complete release (often posted on Business Wire or the Cardlytics investor relations site) sometimes includes a “Guidance” or “Outlook” section that isn’t captured in brief summaries.
2. Review the earnings call transcript – Companies frequently provide guidance verbally during the post‑release conference call. Transcripts are usually posted on the investor‑relations page shortly after the call.
3. Search SEC filings – A Form 8‑K filed around the same date may contain a “Management’s Discussion and Analysis” section with forward‑looking statements, including any guidance the company chose to disclose.
4. Monitor subsequent releases – If Cardlytics does not give guidance now, it may issue an update later in the year (e.g., after Q3 results) that includes the missing outlook.

Bottom line: In the provided news excerpt, Cardlytics did not give any guidance or outlook for Q3 2025 or the full‑year 2025. To obtain that information, you’ll need to consult the complete earnings release, the accompanying earnings‑call transcript, or any related SEC filings.